Designation of 14 Counties as High Intensity Drug Trafficking Areas, 10289 [2016-04291]
Download as PDF
Federal Register / Vol. 81, No. 39 / Monday, February 29, 2016 / Notices
10289
ATTACHMENT 1—GENERAL TARGET SCHEDULE FOR PROCESSING AND RESOLVING REQUESTS FOR ACCESS TO SENSITIVE
UNCLASSIFIED NON-SAFEGUARDS INFORMATION IN THIS PROCEEDING—Continued
Day
Event/activity
A + 28 ......
Deadline for submission of contentions whose development depends upon access to SUNSI. However, if more than 25 days remain between the petitioner’s receipt of (or access to) the information and the deadline for filing all other contentions (as established in the notice of hearing or opportunity for hearing), the petitioner may file its SUNSI contentions by that later deadline.
(Contention receipt +25) Answers to contentions whose development depends upon access to SUNSI.
(Answer receipt +7) Petitioner/Intervenor reply to answers.
Decision on contention admission.
A + 53 ......
A + 60 ......
>A + 60 ....
OVERSEAS PRIVATE INVESTMENT
CORPORATION
BILLING CODE 7590–01–P
EXECUTIVE OFFICE OF THE
PRESIDENT
Designation of 14 Counties as High
Intensity Drug Trafficking Areas
Office of National Drug Control
Policy.
ACTION:
Notice of HIDTA designations.
The Director of the Office of
National Drug Control Policy designated
14 additional counties as High Intensity
Drug Trafficking Areas (HIDTA)
pursuant to 21 U.S.C. 1706. The new
counties are (1) Blount County,
Tennessee and Carroll and Grayson
Counties (including the Independent
City of Galax) in Virginia as part of the
Appalachia HIDTA; (2) Escambia and
Santa Rosa Counties in Florida as part
of the Gulf Coast HIDTA; (3) Muskegon
County, Michigan as part of the
Michigan HIDTA; (4) Bristol County,
Massachusetts as part of the New
England HIDTA; (5) Broome and Ulster
Counties in New York as part of the
New York/New Jersey HIDTA; (6) Linn
County, Oregon as part of the OregonIdaho HIDTA; (7) McIntosh and
Pittsburg Counties in Oklahoma as part
of the Texoma HIDTA; (8) Carroll
County, Maryland and Jefferson County,
West Virginia as part of the Washington/
Baltimore HIDTA.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Proposed Submission of Information
Collection for OMB Review; Comment
Request; Administrative Appeals
Thursday, March 17,
2016, 2 p.m. (Open Portion) 2:15 p.m.
(Closed Portion).
TIME AND DATE:
Office of National Drug Control Policy
AGENCY:
PENSION BENEFIT GUARANTY
CORPORATION
Sunshine Act Meeting Notice
[FR Doc. 2016–04337 Filed 2–26–16; 8:45 am]
Questions regarding this notice should
be directed to Michael K. Gottlieb,
National HIDTA Program Director,
Office of National Drug Control Policy,
Executive Office of the President,
Washington, DC 20503; (202) 395–4868.
Offices of the Corporation,
Twelfth Floor Board Room,1100 New
York Avenue NW., Washington, DC.
PLACE:
Meeting OPEN to the Public
from 2 p.m. to 2:15 p.m. Closed portion
will commence at 2:15 p.m. (approx.)
STATUS:
MATTERS TO BE CONSIDERED:
1. President’s Report
2. Confirmation—Tracey Webb
3. Minutes of the Open Session of the
December 10, 2015 Board of
Directors Meeting
FURTHER MATTERS TO BE CONSIDERED:
(Closed to the Public 2:15 p.m.):
1. Finance Project—Indonesia
2. Finance Project—India
3. Finance Project—India
4. Finance Project—Guinea
5. Finance Project—Cambodia
6. Finance Project—Cambodia
7. Finance Project—Global
8. Minutes of the Closed Session of the
December 19, 2015 Board of
Directors Meeting
9. Formation of a Risk Committee of the
Board
10. Reports
11. Pending Projects
CONTACT PERSON FOR MORE INFORMATION:
Information on the meeting may be
obtained from Catherine F. I. Andrade at
(202) 336–8768, or via email at
Catherine.Andrade@opic.gov.
Dated: January 14, 2016.
Michael Passante,
Deputy General Counsel.
Dated: February 25, 2016.
Catherine F. I. Andrade,
Corporate Secretary, Overseas Private
Investment Corporation.
[FR Doc. 2016–04291 Filed 2–26–16; 8:45 am]
[FR Doc. 2016–04476 Filed 2–25–16; 4:15 pm]
BILLING CODE 3280–F5–P
BILLING CODE 3210–01–P
VerDate Sep<11>2014
19:23 Feb 26, 2016
Jkt 238001
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
Pension Benefit Guaranty
Corporation.
ACTION: Notice of intent to request
extension of OMB approval of
information collection.
AGENCY:
The Pension Benefit Guaranty
Corporation (‘‘PBGC’’) intends to
request the Office of Management and
Budget (‘‘OMB’’) to extend approval,
under the Paperwork Reduction Act, of
a collection of information under its
regulation on Rules for Administrative
Review of Agency Decisions. This
notice informs the public of PBGC’s
intent and solicits public comment on
the collection of information.
DATES: Comments should be submitted
by April 29, 2016.
ADDRESSES: Comments may be
submitted by any of the following
methods:
Federal eRulemaking Portal: https://
www.regulations.gov. Follow the Web
site instructions for submitting
comments.
Email: paperwork.comments@
pbgc.gov.
Fax: 202–326–4224.
Mail or Hand Delivery: Office of the
General Counsel, Pension Benefit
Guaranty Corporation, 1200 K Street
NW., Washington, DC 20005–4026.
PBGC will make all comments
available on its Web site, www.pbgc.gov.
Copies of the collection of
information may also be obtained
without charge by writing to the
Disclosure Division of the Office of the
General Counsel of PBGC at the above
address or by visiting the Disclosure
Division or calling 202–326–4040
during normal business hours. (TTY and
TDD users may call the Federal relay
service toll-free at 1–800–877–8339 and
ask to be connected to 202–326–4040.)
PBGC’s regulation on Administrative
Appeals may be accessed on PBGC’s
Web site at www.pbgc.gov.
SUMMARY:
E:\FR\FM\29FEN1.SGM
29FEN1
Agencies
[Federal Register Volume 81, Number 39 (Monday, February 29, 2016)]
[Notices]
[Page 10289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04291]
=======================================================================
-----------------------------------------------------------------------
EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy
Designation of 14 Counties as High Intensity Drug Trafficking
Areas
AGENCY: Office of National Drug Control Policy.
ACTION: Notice of HIDTA designations.
-----------------------------------------------------------------------
SUMMARY: The Director of the Office of National Drug Control Policy
designated 14 additional counties as High Intensity Drug Trafficking
Areas (HIDTA) pursuant to 21 U.S.C. 1706. The new counties are (1)
Blount County, Tennessee and Carroll and Grayson Counties (including
the Independent City of Galax) in Virginia as part of the Appalachia
HIDTA; (2) Escambia and Santa Rosa Counties in Florida as part of the
Gulf Coast HIDTA; (3) Muskegon County, Michigan as part of the Michigan
HIDTA; (4) Bristol County, Massachusetts as part of the New England
HIDTA; (5) Broome and Ulster Counties in New York as part of the New
York/New Jersey HIDTA; (6) Linn County, Oregon as part of the Oregon-
Idaho HIDTA; (7) McIntosh and Pittsburg Counties in Oklahoma as part of
the Texoma HIDTA; (8) Carroll County, Maryland and Jefferson County,
West Virginia as part of the Washington/Baltimore HIDTA.
FOR FURTHER INFORMATION CONTACT: Questions regarding this notice should
be directed to Michael K. Gottlieb, National HIDTA Program Director,
Office of National Drug Control Policy, Executive Office of the
President, Washington, DC 20503; (202) 395-4868.
Dated: January 14, 2016.
Michael Passante,
Deputy General Counsel.
[FR Doc. 2016-04291 Filed 2-26-16; 8:45 am]
BILLING CODE 3280-F5-P